Relmada Therapeutics
RLMD
#8408
Rank
HK$2.19 B
Marketcap
HK$20.54
Share price
-15.76%
Change (1 day)
-38.20%
Change (1 year)

EPS for Relmada Therapeutics (RLMD)

EPS in 2026 (TTM): -HK$7.28

According to Relmada Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$7.29. In 2025 the company made an earnings per share (EPS) of -HK$11.37 an increase over its 2024 EPS that were of -HK$20.77.

EPS history for Relmada Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$7.28-35.98%
2025-HK$11.37-45.28%
2024-HK$20.77-19.21%
2023-HK$25.71-38.11%
2022-HK$41.54-25.98%
2021-HK$56.1287.93%
2020-HK$29.8739.05%
2019-HK$21.48-4.2%
2018-HK$22.4237.5%
2017-HK$16.30100%
2016-HK$8.15-87.56%
2015-HK$65.53
2013-HK$0.25273.48%
2012-HK$0.06630

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Cytokinetics
CYTK
-HK$47.35 549.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
HK$9.56-231.18%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel